Genentech profit up on Avastin, Rituxan
240917
Genentech Inc.  on Wednesday said second-quarter profit rose 41 percent, fueled by growth from key cancer drugs Avastin and Rituxan, and it boosted its full-year profit forecast.
331670
Medco Health Solutions Inc  on Tuesday posted higher-than-expected quarterly earnings, helped by sales of generic drugs, and the pharmacy benefit manager boosted its full-year profit forecast.
275333
Medco Health Solutions Inc. , one of the largest U.S. managers of drug benefits, said on Wednesday that profit rose 29 percent, as higher rates of mail-delivered generic drugs drove better profit margins, and it lifted its full-year earnings forecast.
244313
BASEL, Switzerland  - Core net profit at Roche  Holding AG rose by less than expected in 2004 despite strong  sales of cancer drugs, as products such as flu drug Tamiflu  suffered a weaker fourth quarter.
73002
Genentech Inc.  said on  Tuesday second-quarter net income rose 79 percent on higher  demand for cancer medicines and raised its full-year forecast,  but its stock fell as sales of colon cancer drug Avastin  disappointed investors.
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
15948
Genentech reported a 6 percent rise in fourth-quarter profit, but its stock slipped after news that its cancer drug, Avastin, failed to meet sales expectations.
67048
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including newer treatments for depression, diabetes and cancer.
549877
The drug maker Schering-Plough Corporation said yesterday that its fourth-quarter profit surged 75 percent as strong sales of its cholesterol, arthritis and allergy medicines helped offset rising research and marketing spending.
312721
The biotechnology company reported fourth-quarter net income of $201.2 million on strong sales of its two leading drugs, Rituxan and Avonex.
766797
Genentech Inc.  on Monday said its colon cancer drug Avastin extended the life of patients when used in combination with a chemotherapy regimen called FOLFOX4 more than the chemotherapy alone in a late stage clinical trial.
382374
The Swiss pharmaceutical giant, Novartis, on Tuesday announced an 18 percent increase in second quarter net profit to 2.02 billion dollars (1.46 billion euros) and reiterated its forecast of record profits this year.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
66960
Genentech Inc. barely scraped past Wall Street's expectations Monday as the biotech giant renowned for its phenomenal growth posted a 6 percent rise in fourth-quarter profits.
177682
Genentech appears to have resolved a dispute with ophthalmologists that will allow its drug Avastin to continue to be used to treat eye diseases, boths sides said.
581460
Genentech announces positive second-quarter results, but investors remain worried.
509470
Pharmaceutical giant GlaxoSmithKline PLC reported a 21 percent increase in fourth-quarter net profit on Thursday, as additional offerings of its key anti-depressant drugs began to offset some of the generic competition that has curtailed the company's sales.